Anemia Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: A2EB62B22FB0EN
Market Monitor Global

Abstracts

Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia.

This report contains market size and forecasts of Anemia Therapeutics in Global, including the following market information:

Global Anemia Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anemia Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Iron Deficiency Anemia Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anemia Therapeutics include Sanofi, Acceleron Pharma, Bayer, GlaxoSmithKline, Novartis, Pieris Pharmaceuticals, AMAG Pharmaceuticals, Daiichi Sankyo and Galenica and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anemia Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anemia Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anemia Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Iron Deficiency Anemia
• Sickle Cell Anemia
• Pernicious Anemia
• Hemolytic Anemia

Global Anemia Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anemia Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Anemia Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anemia Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anemia Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anemia Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Acceleron Pharma
• Bayer
• GlaxoSmithKline
• Novartis
• Pieris Pharmaceuticals
• AMAG Pharmaceuticals
• Daiichi Sankyo
• Galenica
• Pharmacosmos

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anemia Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anemia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANEMIA THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Anemia Therapeutics Market Size: 2021 VS 2028
2.2 Global Anemia Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anemia Therapeutics Players in Global Market
3.2 Top Global Anemia Therapeutics Companies Ranked by Revenue
3.3 Global Anemia Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Anemia Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anemia Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anemia Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Anemia Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anemia Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anemia Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Iron Deficiency Anemia
  4.1.3 Sickle Cell Anemia
  4.1.4 Pernicious Anemia
  4.1.5 Hemolytic Anemia
4.2 By Type - Global Anemia Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Anemia Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Anemia Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Anemia Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anemia Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Anemia Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Anemia Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Anemia Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Anemia Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anemia Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Anemia Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Anemia Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Anemia Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Anemia Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anemia Therapeutics Revenue, 2017-2028
  6.3.2 US Anemia Therapeutics Market Size, 2017-2028
  6.3.3 Canada Anemia Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Anemia Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anemia Therapeutics Revenue, 2017-2028
  6.4.2 Germany Anemia Therapeutics Market Size, 2017-2028
  6.4.3 France Anemia Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Anemia Therapeutics Market Size, 2017-2028
  6.4.5 Italy Anemia Therapeutics Market Size, 2017-2028
  6.4.6 Russia Anemia Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Anemia Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Anemia Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anemia Therapeutics Revenue, 2017-2028
  6.5.2 China Anemia Therapeutics Market Size, 2017-2028
  6.5.3 Japan Anemia Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Anemia Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Anemia Therapeutics Market Size, 2017-2028
  6.5.6 India Anemia Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anemia Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Anemia Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Anemia Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anemia Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Anemia Therapeutics Market Size, 2017-2028
  6.7.3 Israel Anemia Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Anemia Therapeutics Market Size, 2017-2028
  6.7.5 UAE Anemia Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Anemia Therapeutics Major Product Offerings
  7.1.4 Sanofi Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Acceleron Pharma
  7.2.1 Acceleron Pharma Corporate Summary
  7.2.2 Acceleron Pharma Business Overview
  7.2.3 Acceleron Pharma Anemia Therapeutics Major Product Offerings
  7.2.4 Acceleron Pharma Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Acceleron Pharma Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Anemia Therapeutics Major Product Offerings
  7.3.4 Bayer Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Bayer Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Anemia Therapeutics Major Product Offerings
  7.4.4 GlaxoSmithKline Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Anemia Therapeutics Major Product Offerings
  7.5.4 Novartis Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Pieris Pharmaceuticals
  7.6.1 Pieris Pharmaceuticals Corporate Summary
  7.6.2 Pieris Pharmaceuticals Business Overview
  7.6.3 Pieris Pharmaceuticals Anemia Therapeutics Major Product Offerings
  7.6.4 Pieris Pharmaceuticals Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Pieris Pharmaceuticals Key News
7.7 AMAG Pharmaceuticals
  7.7.1 AMAG Pharmaceuticals Corporate Summary
  7.7.2 AMAG Pharmaceuticals Business Overview
  7.7.3 AMAG Pharmaceuticals Anemia Therapeutics Major Product Offerings
  7.7.4 AMAG Pharmaceuticals Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 AMAG Pharmaceuticals Key News
7.8 Daiichi Sankyo
  7.8.1 Daiichi Sankyo Corporate Summary
  7.8.2 Daiichi Sankyo Business Overview
  7.8.3 Daiichi Sankyo Anemia Therapeutics Major Product Offerings
  7.8.4 Daiichi Sankyo Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Daiichi Sankyo Key News
7.9 Galenica
  7.9.1 Galenica Corporate Summary
  7.9.2 Galenica Business Overview
  7.9.3 Galenica Anemia Therapeutics Major Product Offerings
  7.9.4 Galenica Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Galenica Key News
7.10 Pharmacosmos
  7.10.1 Pharmacosmos Corporate Summary
  7.10.2 Pharmacosmos Business Overview
  7.10.3 Pharmacosmos Anemia Therapeutics Major Product Offerings
  7.10.4 Pharmacosmos Anemia Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Pharmacosmos Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anemia Therapeutics Market Opportunities & Trends in Global Market
Table 2. Anemia Therapeutics Market Drivers in Global Market
Table 3. Anemia Therapeutics Market Restraints in Global Market
Table 4. Key Players of Anemia Therapeutics in Global Market
Table 5. Top Anemia Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anemia Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anemia Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anemia Therapeutics Product Type
Table 9. List of Global Tier 1 Anemia Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anemia Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anemia Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anemia Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anemia Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anemia Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anemia Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anemia Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anemia Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anemia Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anemia Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anemia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anemia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anemia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anemia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anemia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anemia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anemia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anemia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anemia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anemia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Anemia Therapeutics Product Offerings
Table 32. Sanofi Anemia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Acceleron Pharma Corporate Summary
Table 34. Acceleron Pharma Anemia Therapeutics Product Offerings
Table 35. Acceleron Pharma Anemia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Anemia Therapeutics Product Offerings
Table 38. Bayer Anemia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Anemia Therapeutics Product Offerings
Table 41. GlaxoSmithKline Anemia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Anemia Therapeutics Product Offerings
Table 44. Novartis Anemia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Pieris Pharmaceuticals Corporate Summary
Table 46. Pieris Pharmaceuticals Anemia Therapeutics Product Offerings
Table 47. Pieris Pharmaceuticals Anemia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. AMAG Pharmaceuticals Corporate Summary
Table 49. AMAG Pharmaceuticals Anemia Therapeutics Product Offerings
Table 50. AMAG Pharmaceuticals Anemia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Daiichi Sankyo Corporate Summary
Table 52. Daiichi Sankyo Anemia Therapeutics Product Offerings
Table 53. Daiichi Sankyo Anemia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Galenica Corporate Summary
Table 55. Galenica Anemia Therapeutics Product Offerings
Table 56. Galenica Anemia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Pharmacosmos Corporate Summary
Table 58. Pharmacosmos Anemia Therapeutics Product Offerings
Table 59. Pharmacosmos Anemia Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anemia Therapeutics Segment by Type in 2021
Figure 2. Anemia Therapeutics Segment by Application in 2021
Figure 3. Global Anemia Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anemia Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anemia Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anemia Therapeutics Revenue in 2021
Figure 8. By Type - Global Anemia Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anemia Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anemia Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anemia Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anemia Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anemia Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anemia Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anemia Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anemia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Acceleron Pharma Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pieris Pharmaceuticals Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AMAG Pharmaceuticals Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Daiichi Sankyo Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Galenica Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pharmacosmos Anemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)